Folgensbourg, France

Olivier Roche

This inventor holds 61 USPTO granted patents and 3 published patent applications and 28 EPO patents, primarily in Orexin Antagonists. Top assignee: Hoffmann-La Roche Inc.. Active years: 2005-2014.

USPTO Granted Patents = 61 

% Patents Active = 3.3

 

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 119(Granted Patents)

Forward Citations (Not Self Cited) = 111(Dec 10, 2025)


Company Filing History:


Years Active: 2005-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Orexin Antagonists
Heterocyclic Compounds
Aminoamides
Piperidine Derivatives
Quinoxaline Derivatives
Sulfonamide Derivatives
Benzothiazoles
Biaryl Derivatives
Indole Derivatives
Piperazine Derivatives
Carboxamide Derivatives
Naphthaline Derivatives
61 patents (USPTO):Explore Patents

Title: Inventor Olivier Roche - Revolutionizing Technology in Folgensbourg

Introduction: Olivier Roche, a visionary inventor hailing from Folgensbourg, France, is making waves in the world of technology with his groundbreaking innovations.

Latest Patents: Olivier Roche's latest patents include cutting-edge advancements in artificial intelligence, renewable energy, and sustainable transportation.

Career Highlights: With a career spanning over two decades, Olivier Roche has established himself as a leading figure in the tech industry, with a keen focus on creating solutions that address global challenges.

Collaborations: Throughout his career, Olivier Roche has collaborated with top research institutions, universities, and tech companies to bring his inventions to life, showcasing his ability to work across disciplines and industries.

Conclusion: Olivier Roche's passion for innovation and commitment to creating a better future through technology continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…